COVID-19 Changed Telehealth

3

August 4, 2020 brings Permanence to a projected $250Billion Telehealth Market

DALLAS, TX. November 2020–AvodahMed, a paradigm in telehealth, has patented artificial intelligence technology that provides a unique solution of real time vital checking, video conferencing, patient data analytics and language services embedded with AI. Today they announced that the company is uniquely positioned to take advantage of the current market demand.

Shawn Ring, President and CEO of AvodahMed said: “Post-pandemic, the world was faced with a new set of challenges when providing healthcare for people. Due to the influx of patients with COVID-19, who needed immediate care, hospitals and urgent cares became less accessible. These, and several more challenges led to telehealth deregulation. What was first temporarily passed on March 20th, 2020, is now permanent through an Executive Order released on August 3rd, 2020.”

Projected 50X growth of telehealth market

Ring continued: “Now the question is, how does this affect the telehealth market? McKinsey and Company reports a projected staggering growth to $250B, which is 50X 2019 actuals, due to both the deregulation and the pandemic impact. Traditional healthcare providers recognize, and are looking for, solutions to meet the new remote healthcare demand. Telehealth is now a patient-driven market. Doctors and lawmakers are following suit and AvodahMed is right in the middle of that demand curve.”

AvodahMed is open to hearing from investors. If you are interested in learning more, connect with our team.

Press Contact:
Mariam Varghese
AvodahMed
mariam.varghese@AvodahMed.com

Investor Contact:
Alex Lagerborg
AvodahMed
alex.lagerborg@AvodahMed.com